Updated Vaccine Information
This week, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) issued a statement recommending a pause in the use of the Johnson & Johnson (J&J) vaccine out of an abundance of caution. This pause is following six reported cases of a rare type of blood clot out of the 6.8 million J&J vaccine doses that have been administered; this represents a .0000008 percentage. For More information visit our website by clicking the following link, and reach out to your Care Manager for support as needed.
If you received the J&J vaccine, please note the following time periods:
Within 48 hours of receiving a dose of the J&J vaccine, you may experience a headache as a common side effect along with fever, fatigue, etc.
Less than one week-- no clotting cases have been reported.
One to three weeks—contact your primary care provider if you develop a severe lasting headache, abdominal pain, shortness of breath, or severe leg pain.
More than 3 weeks ago-- you have no risk based on our current analysis.
See more on our website about COVID-19 Vaccine Distribution here.
